NCT05239169 2025-05-01Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract CancerInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestPhase 2 Completed40 enrolled